Close Menu

NEW YORK – Adding RNA-based genetic testing to DNA tests can clarify what variants of uncertain significance in hereditary cancer genes mean and change how patients' care is managed, according to a new analysis led by researchers at Ambry Genetics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.